Effect of vitamin D supplementation on glycaemic control and insulin resistance: A systematic review and meta-analysis

Diabetic Medicine

Volumn 29, Issue 8, 2012, Pages

  George, P S ^a   Pearson, E R ^a   Witham, M D ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Glycaemia; Randomized controlled trial; Systematic review; VitaminD

Indexed keywords

1ALPHA CALCIDOL; C PEPTIDE; CALCITRIOL; CALCIUM; COLECALCIFEROL; DOXERCALCIFEROL; ERGOCALCIFEROL; GLUCOSE; HEMOGLOBIN A1C; INSULIN; PARICALCITOL; PLACEBO; UNCLASSIFIED DRUG; VITAMIN D;

DIABETES MELLITUS; DISEASE COURSE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INSULIN TREATMENT; META ANALYSIS; REVIEW; SYSTEMATIC REVIEW; VITAMIN SUPPLEMENTATION;

ADULT; AGED; BLOOD GLUCOSE; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; FASTING; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS;

EID: 84863996265     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2012.03672.x     Document Type: Review

References (40)

1. Scragg R, Holdaway I, Singh V, Metcalf P, Baker J, Dryson E. Serum 25-hydroxyvitamin D3 levels decreased in impaired glucose tolerance and diabetes mellitus. Diabetes Res Clin Pract 1995; 27: 181-188.
2. Cigolini M, Iagulli MP, Miconi V, Galiotto M, Lombardi S, Targher G. Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type2 diabetic patients. Diabetes Care 2006; 29: 722-724.
3. Sugden JA, Davies JI, Witham MD, Morris AD, Struthers AD. VitaminD improves endothelial function in patients with Type2 diabetes mellitus and low vitaminD levels. Diabet Med 2008; 25: 320-325.
4. Joergensen C, Gall MA, Schmedes A, Tarnow L, Parving HH, Rossing P. VitaminD levels and mortality in type2 diabetes. Diabetes Care 2010; 33: 2238-2243.
5. Hypponen E, Power C. VitaminD status and glucose homeostasis in the 1958 British birth cohort: the role of obesity. Diabetes Care 2006; 29: 2244-2246.
6. Kositsawat J, Freeman VL, Gerber BS, Geraci S. Association of A1C levels with vitaminD status in US adults: data from the National Health and Nutrition Examination Survey. Diabetes Care 2010; 33: 1236-1238.
7. Hypponen E, Boucher BJ, Berry DJ, Power C. 25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45years of age: a cross-sectional study in the 1958 British Birth Cohort. Diabetes 2008; 57: 298-305.
8. Knekt P, Laaksonen M, Mattila C, Harkanen T, Marniemi J, Heliovaara M et al. Serum vitaminD and subsequent occurrence of type2 diabetes. Epidemiology 2008; 19: 666-671.
9. Grimnes G, Emaus N, Joakimsen RM, Figenschau Y, Jenssen T, Njolstad I et al. Baseline serum 25-hydroxyvitaminD concentrations in the Tromso Study 1994-1995 and risk of developing Type2 diabetes mellitus during 11years of follow-up. Diabet Med 2010; 27: 1107-1115.
10. Hewison M. VitaminD and the immune system: new perspectives on an old theme. Endocrinol Metab Clin North Am 2010; 39: 365-379.
11. Kolb H, Mandrup-Poulsen T. An immune origin of type2 diabetes? Diabetologia 2005; 48: 1038-1050.
12. Pitocco D, Crino A, Di Stasio E, Manfrini S, Guglielmi C, Spera S et al. The effects of calcitriol and nicotinamide on residual pancreatic β-cell function in patients with recent-onset Type1 diabetes (IMDIAB XI). Diabet Med 2006; 23: 920-923.
13. Borissova AM, Tankova T, Kirilov G, Dakovska L, Kovacheva R. The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type2 diabetic patients. Int J Clin Pract 2003; 57: 258-261.
14. Fadda GZ, Akmal M, Lipson LG, Massry SG. Direct effect of parathyroid hormone on insulin secretion from pancreatic islets. Am J Physiol 1990; 258: E975-E984.
15. Joergensen C, Hovind P, Schmedes A, Parving HH, Rossing P. VitaminD levels, microvascular complications, and mortality in type1 diabetes. Diabetes Care 2011; 34: 1081-1085.
16. Witham MD, Nadir MA, Struthers AD. Effect of vitaminD on blood pressure - a systematic review and meta-analysis. J Hypertens 2009; 27: 1948-1954.
17. Forman JP, Williams JS, Fisher ND. Plasma 25-hydroxyvitaminD and regulation of the rennin-angiotensin system in humans. Hypertension 2010; 55: 1283-1288.
18. Cardus A, Panizo S, Encinas M, Dolcet X, Gallego C, Aldea M et al. 1, 25-dihydroxyvitamin D3 regulates VEGF production through a vitaminD response element in the VEGF promoter. Atherosclerosis 2009; 204: 85-89.
19. Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitaminD and calcium in type2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 2007; 92: 2017-2029.
20. Cappuccio FP, Kerry SM, Forbes L, Donald A. Blood pressure control by home monitoring: meta-analysis of randomised trials. Br Med J 2004; 329: 145-150.
21. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
22. Witham MD, Dove FJ, Dryburgh M, Morris AD, Struthers AD. The effect of different doses of vitamin D3 on markers of vascular health in patients with type2 diabetes-a randomised controlled trial. Diabetologia 2010; 53: 2112-2119.
23. Ljunghall S, Lind L, Lithell H, Skarfors E, Selinus I, Sorensen OH et al. Treatment with one-alpha-hydroxycholecalciferol in middle-aged men with impaired glucose tolerance-a prospective randomized double-blind study. Acta Med Scand 1987; 222: 361-367.
24. Nilas L, Christiansen C. Treatment with vitaminD or its analogues does not change body weight or blood glucose level in postmenopausal women. Int J Obes 1984; 8: 407-411.
25. Pittas AG, Harris SS, Stark PC, Dawson-Hughes B. The effects of calcium and vitaminD supplementation on blood glucose and markers of inflammation in non-diabetic adults. Diabetes Care 2007; 30: 980-986.
26. Major GC, Alarie F, Dore J, Phouttama S, Tremblay A. Supplementation with calcium + vitaminD enhances the beneficial effect of weight loss on plasma lipid and lipoprotein concentrations. Am J Clin Nutr 2007; 85: 54-59.
27. de Boer IH, Tinker LF, Connelly S, Curb JD, Howard BV, Kestenbaum B et al. Calcium plus vitaminD supplementation and the risk of incident diabetes in the Women's Health Initiative. Diabetes Care 2008; 31: 701-707.
28. Fliser D, Stefanski A, Franek E, Fode P, Gudarzi A, Ritz E. No effect of calcitriol on insulin-mediated glucose uptake in healthy subjects. Eur J Clin Invest 1997; 27: 629-633.
29. de Zeeuw D, Agarwal R, Amdahl M, Audhya P, Coyne D, Garimella T et al. Selective vitaminD receptor activation with paricalcitol for reduction of albuminuria in patients with type2 diabetes (VITAL study): a randomised controlled trial. Lancet 2010; 376: 1543-1551.
30. Avenell A, Cook JA, Maclennan GS, McPherson GC. VitaminD supplementation and type2 diabetes: a substudy of a randomised placebo-controlled trial in older people (RECORD trial, ISRCTN 51647438). Age Ageing 2009; 38: 606-609.
31. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitaminD for multiple health outcomes. Am J Clin Nutr 2006; 84: 18-28.
32. Aloia JF, Patel M, Dimaano R, Li-Ng M, Talwar SA, Mikhail M et al. VitaminD intake to attain a desired serum 25-hydroxyvitaminD concentration. Am J Clin Nutr 2008; 87: 1952-1958.
33. Liu S, Song Y, Ford ES, Manson JE, Buring JE, Ridker PM. Dietary calcium, vitaminD, and the prevalence of metabolic syndrome in middle-aged and older US women. Diabetes Care 2005; 28: 2926-2932.
34. Dickinson HO, Nicolson DJ, Cook JV, Campbell F, Beyer FR, Ford GA et al. Calcium supplementation for the management of primary hypertension in adults. Cochrane Database Syst Rev 2006; 19: CD004639.
35. Pittas AG, Dawson-Hughes B, Li T, Van Dam RM, Willett WC, Manson JE et al. VitaminD and calcium intake in relation to type2 diabetes in women. Diabetes Care 2006; 29: 650-656.
36. Orwoll E, Riddle M, Prince M. Effects of vitaminD on insulin and glucagon secretion in non-insulin-dependent diabetes mellitus. Am J Clin Nutr 1994; 59: 1083-1087.
37. Li X, Liao L, Yan X, Huang G, Lin J, Lei M et al. Protective effects of 1-alpha-hydroxyvitamin D3 on residual beta-cell function in patients with adult-onset latent autoimmune diabetes (LADA). Diabetes Metab Res Rev 2009; 25: 411-416.
38. Jorde R, Figenschau Y. Supplementation with cholecalciferol does not improve glycaemic control in diabetic subjects with normal serum 25-hydroxyvitaminD levels. Eur J Nutr 2009; 48: 349-354.
39. Nagpal J, Pande JN, Bhartia A. A double-blind, randomized, placebo-controlled trial of the short-term effect of vitaminD3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men. Diabet Med 2009; 26: 19-27.
40. von Hurst PR, Stonehouse W, Coad J. VitaminD supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitaminD deficient - a randomised, placebo-controlled trial. Br J Nutr 2010; 103: 549-555.